Explore more publications!
Health Wire Taiwan
Got News to Share?

Press Releases

EyePoint to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025

EyePoint to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire, Inc.
Dietary Supplements Market Size Expected to Reach USD 430.39 Bn by 2034 Driven by Preventive Healthcare, Personalized Nutrition, and Rising Health Awareness
December 17, 2025

Dietary Supplements Market Size Expected to Reach USD 430.39 Bn by 2034 Driven by Preventive Healthcare, Personalized Nutrition, and Rising Health Awareness

Indeterminate GlobeNewswire, Inc.
Trends in Pharmaceutical Cold Chain Logistics Packaging Market
December 16, 2025

Trends in Pharmaceutical Cold Chain Logistics Packaging Market

Indeterminate GlobeNewswire, Inc.
Luminous Plants Offer New Path for Carbon Reduction and Biodiversity Protection
December 17, 2025

Luminous Plants Offer New Path for Carbon Reduction and Biodiversity Protection

Neutral EIN Presswire
NovelWise Pharma Announces First Patient Dosed in Phase I/II Trial of NBM-BMX for Metastatic Uveal Melanoma
December 15, 2025

NovelWise Pharma Announces First Patient Dosed in Phase I/II Trial of NBM-BMX for Metastatic Uveal Melanoma

Neutral EIN Presswire
China, Japan, S. Korea to meet this weekend despite Taiwan tensions
December 13, 2025

China, Japan, S. Korea to meet this weekend despite Taiwan tensions

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

Medical Devices Market Size Worth USD 1,209.42 Bn by 2035 Fueled by Advances in Diagnostic Technologies
December 10, 2025

Medical Devices Market Size Worth USD 1,209.42 Bn by 2035 Fueled by Advances in Diagnostic Technologies

Indeterminate GlobeNewswire, Inc.
Taiwan’s 2025 Mobileheroes Competition Winners Announced: Seizing 5G and AI Market Opportunities in Taiwan and Asia
December 10, 2025

Taiwan’s 2025 Mobileheroes Competition Winners Announced: Seizing 5G and AI Market Opportunities in Taiwan and Asia

Neutral EIN Presswire
Avalue MAB Series Delivers Scalable Medical-Grade Edge Intelligence for Precision Care
December 11, 2025

Avalue MAB Series Delivers Scalable Medical-Grade Edge Intelligence for Precision Care

Neutral EIN Presswire
mRNA Quality Monitoring Market to Reach USD 2.5 Billion by 2034, Driven by Expanding Healthcare Applications
December 11, 2025

mRNA Quality Monitoring Market to Reach USD 2.5 Billion by 2034, Driven by Expanding Healthcare Applications

Indeterminate GlobeNewswire, Inc.
Trends in Sterile Medical Packaging Market 2025-2035
December 10, 2025

Trends in Sterile Medical Packaging Market 2025-2035

Indeterminate GlobeNewswire, Inc.
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
December 9, 2025

YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN

Indeterminate GlobeNewswire, Inc.
Real-World Data (RWD) Market Size Worth USD 6.37 Bn by 2034 Driven by AI Adoption, Precision Medicine, and Drug Development Demand
December 9, 2025

Real-World Data (RWD) Market Size Worth USD 6.37 Bn by 2034 Driven by AI Adoption, Precision Medicine, and Drug Development Demand

Indeterminate GlobeNewswire, Inc.
ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%
December 9, 2025

ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%

Indeterminate GlobeNewswire, Inc.
ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant CML-CP
December 9, 2025

ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant CML-CP

Indeterminate GlobeNewswire, Inc.
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
December 16, 2025

YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center

Indeterminate GlobeNewswire, Inc.
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
December 9, 2025

ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment

Indeterminate GlobeNewswire, Inc.
rYojbaba Subsidiary Sakai Seikotsuin Serves as an Official Trainer at the 2025 Taipei Wake Open
December 8, 2025

rYojbaba Subsidiary Sakai Seikotsuin Serves as an Official Trainer at the 2025 Taipei Wake Open

Indeterminate GlobeNewswire, Inc.
Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows
December 8, 2025

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows

Indeterminate GlobeNewswire, Inc.
In Vitro Diagnostics (IVD) Market Size Forecast to Surge to USD 135.76 Billion by 2035 Driven by Point-of-Care and AI Innovations
December 16, 2025

In Vitro Diagnostics (IVD) Market Size Forecast to Surge to USD 135.76 Billion by 2035 Driven by Point-of-Care and AI Innovations

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions